Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: a gynecologic oncology group study. [electronic resource]
Producer: 20140428Description: 585-92 p. digitalISSN:- 1095-6859
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Disease-Free Survival
- Drug Administration Schedule
- Endometrial Neoplasms -- drug therapy
- Female
- Humans
- Immunohistochemistry
- Megestrol Acetate -- administration & dosage
- Middle Aged
- Neoplasm Metastasis
- Neoplasm Recurrence, Local -- drug therapy
- Sirolimus -- administration & dosage
- Tamoxifen -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.